The Awareness and Perception of Health Care Specialists about Precision Medicine

Main Article Content

Nehad J. Ahmed
Abdulrahman S. Alrawili
Faisal Z. Alkhawaja
Mohammad Javed Ansari

Abstract

Aim: There are a small number of studies about the populations' knowledge and perceptions on precision medicine in Saudi Arabia till now. Therefore, this study aimed to assess the awareness and knowledge of health care specialists about precision medicine in Saudi Arabia.

Methodology: This study was a cross sectional study that included an online survey targeting health care specialists. The survey was converted to an online survey using google forms.

Results: More than half of the participants have heard about the different terms of precision medicine. Most of the health care specialists in the present study said that they have an insufficient knowledge about precision medicine (68.00%). Additionally, most of them said that they are interested to learn more about precision medicine and showed a positive attitude about it.

Conclusion: The present study found that health care specialists had a insufficient knowledge about precision medicine but they are interested to learn more about this field. Therefore, more training and awareness programs about precision medicine are needed to ease its introduction in Saudi Arabia.

Keywords:
Awareness, healthcare specialists, knowledge, precision medicine

Article Details

How to Cite
Ahmed, N. J., Alrawili, A. S., Alkhawaja, F. Z., & Ansari, M. J. (2021). The Awareness and Perception of Health Care Specialists about Precision Medicine. Journal of Pharmaceutical Research International, 32(41), 8-14. https://doi.org/10.9734/jpri/2020/v32i4131039
Section
Original Research Article

References

European Commission. Personalized Medicine; 2015.
Available:https://ec.europa.eu/health/human-use/personalised-medicine_en
[Access 02 July 2020].

Emmert-Streib F. Personalized medicine: Has it started yet? A reconstruction of the early history. Front Genet. 2013;3:313.

Auffray C, Chen Z, Hood L. Systems medicine: The future of medical genomics

and healthcare. Genome Med. 2009;1(1): 2.

Chen R, Mias GI, Li -Pook-Than J, Jiang L, Lam HY, Chen R, et al. Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell. 2012;148(6): 1293-307.

Ginsburg GS, Willard HF. Genomic and personalized medicine: Foundations and applications. Transl Res. 2009;154(6):277-87.

Paik S, Tang G, Shak S, Kim C, Baker J, Kim W, et al. Gene expression and benefit

of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol. 2006;24(23):3726-34.

Bombard Y, Abelson J, Simeonov D, Gauvin FP. Citizens' perspectives on personalized medicine: A qualitative public deliberation study. Eur J Hum Genet.
;21(11):1197-201.

McDermott U, Downing JR, Stratton MR. Genomics and the continuum of cancer care. N Engl J Med. 2011;364(4): 340-50.

Weitzel JN, Blazer KR, MacDonald DJ, Culver JO, Offit K. Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine. CA Cancer J Clin. 2011;61(5):327-59.

Hudson TJ. Personalized medicine: A transformative approach is needed. CMAJ. 2009;180(9):911-3.

Lyman GH, Cosler LE, Kuderer NM, Hornberger J. Impact of a 21-gene RT-PCR assay on treatment decisions in early-stage breast cancer: An economic

analysis based on prognostic and predictive validation studies. Cancer. 2007;109(6):1011-8.

Armstrong K. Can genomics bend the cost curve? JAMA. 2012;307(10):1031-2.

Doerr M, Eng C. Personalised care and the genome. BMJ. 2012;344:e3174.

Auffray C, Caulfield T, Khoury MJ, Lupski JR, Schwab M, Veenstra T. Genome

medicine: Past, present and future. Genome Med. 2011;3:6.

Personalized Medicine Coalition. Personalized Medicine by the Numbers; 2014.
Available:http://www.personalizedmedicinecoalition.org/Resources/Personalized_Medicine_by_the_Numbers.
[Access 02 July 2020].

Genomic Health. Health Economics; 2016. Available:http://www.genomichealth.com/en-US/Publications/HealthEconomics.aspx. [Access 02 July 2020.

McWilliam A, Lutter RW, Nardinelli C. Health care savings from personalizing

medicine using genetic testing: The case of warfarin. Washington, DC: AEI-Brookings Joint Center for Regulatory Studies. 2006;06-23

Project Team SG. The Saudi human genome program: An oasis in the desert of Arab medicine is providing clues to genetic disease. IEEE Pulse. 2015;6(6):22-6.

Altayyari ST, Omer AR, Aljifri HA, Magadmi BM, Nemri AA, Basheikh MA et al. Knowledge and awareness on personalised medicine amongst medical students: A cross-sectional survey. J Health Spec. 2017;5(3):171-175.

Altemani AH. Knowledge, attitudes, and enthusiasm of primary care physicians regarding personalized medicine practice in Saudi Arabia. IJBAMR. 2017;7(1):518-529.

Lee IH, Kang HY, Suh HS, Lee S, Oh ES, Jeong H. Awareness and attitude of the public toward personalized medicine in Korea. PloS one. 2018;13(2):e0192856.